Boston Scientific Corporation expands upon its core medical device offerings through two primary business segments: MedSurg and Cardiovascular. The MedSurg segment focuses on endoscopy, urology, and pelvic health, while the Cardiovascular segment encompasses cardiology, rhythm management, and peripheral interventions. The company maintains a global geographic footprint, selling its products in over 100 countries and operating manufacturing facilities across the Americas, Europe, and Asia. Key products include the WATCHMAN implant, the Farapulse pulsed field ablation system, drug-eluting coronary stents, and neuromodulation devices. Boston Scientific holds a strong competitive position in the medical technology sector by focusing on minimally invasive procedures that reduce patient trauma and recovery times. The company frequently enhances its technological capabilities and market reach through strategic acquisitions and robust research and development investments.
